Coliforms Diversity and Antibiotic Resistance in Kazakhstan Cheese

2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3844/ajavsp.2024.101.107
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Coliform bacteria contaminate dairy products and pose public health concerns including food poisoning and toxemia. We aimed to determine the species diversity of coliforms and to evaluate the resistance to antibiotics of E. coli in various types of cheese sold by local producers in Kazakhstan. We collected 197 samples from different cheeses sold by producers in the Kostanay (n = 89), East Kazakhstan (n = 70) and Akmola (n = 38) regions and studied by classical microbiological and mass spectrometric methods for contamination with coliforms in certificated for bacterial pathogens’ research laboratories. Such investigation of cheese was experienced the first time in Central Asia. We isolated five coliform bacteria species (Escherichia coli, Citrobacter freundii, Serratia liquefaciens, Enterobacter cloacae and Citrobacter braakii) in 45.2% of the samples. E. coli and C. freundii were dominant. Antibacterial resistance of E. coli isolates (n = 65) to 19 antibiotics was investigated by the disc-diffusion and molecular genetic (PCR) methods. Isolates were sensitive to drugs of the aminoglycosides group and resistant to 60% of the β-lactams group drugs (ampicillin, cefpodoxime, cefoperazone) and to an agent out of four of the fluoroquinolones group (enrofloxacin). Some E. coli strains were multi-drug resistance to tetracyclines, beta-lactams and fluoroquinolones. PCR of E. coli isolates revealed genes that encoded the resistance to β-lactams in 15.4%, to sulfonamides in 30.8% and quinolones in 9.3% of cheese samples, providing sufficient biotic potential for the transfer of these genes to intestinal biocenosis bacteria of humans.